Apellis Pharmaceuticals Inc


Market Cap$6.72B

Compare Apellis Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Apellis Pharmaceuticals IncApellis Pharmaceuticals Inc00%---
marketMarket Avg58.91.26%30%-1
HealthcareHealthcare Avg64.71.29%15%7.30.9

Target Price by Analysts

54.5% upsideApellis Pharmaceuticals Target Price DetailsTarget Price

Current Fair Value

24.4% upside

Undervalued by 24.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.72 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares120,581,749
Avg 30 Day Volume1,056,254


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Apellis Pharmaceuticals Inc

CEO: Cedric Francois